SF
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Assessment of access and outcomes of kidney transplantation through the reforms of the Swiss organ allocation system | Frontiers in public health | 2025 | 119 | 158 | |||
| Incidence and Risk Factors for Infection in Heart Transplant Recipients on Posttransplant Extracorporeal Membrane Oxygenation (ECMO) | Transplantation direct | 2025 | 16 | 39 | |||
| Comparing variable and feature selection strategies for prediction - protocol of a simulation study in low-dimensional transplantation data | PloS one | 2025 | 16 | 121 | |||
| Reintegration Into the Workforce After Kidney Transplantation Based on Urbanization Status in Switzerland | Kidney international reports | 2025 | 106 | 177 | |||
| Outcome of Patients Transplanted for C3 Glomerulopathy and Primary Immune Complex-Mediated Membranoproliferative Glomerulonephritis | Kidney international reports | 2025 | 50 | 246 | |||
| Invasive Candida infections in solid organ transplant recipients between 2008 and 2020 | American Journal of Transplantation | 2025 | 21 | 81 | |||
| Surgical site infections, risk factors, and outcomes after liver transplant | JAMA network open | 2025 | 74 | 208 | |||
| Infectious disease events in people with HIV receiving kidney transplantation : Analysis of the Swiss HIV Cohort Study and the Swiss Transplant Cohort Study | BMC infectious diseases | 2024 | 64 | 122 | |||
| BK polyomavirus serotype-specific antibody responses in blood donors and kidney transplant recipients with and without new-onset BK polyomavirus-DNAemia : A Swiss Transplant Cohort Study | American journal of transplantation | 2024 | 49 | 95 | |||
| Surgical site infections after kidney transplantation are independently associated with graft loss | American journal of transplantation | 2024 | 59 | 200 | |||
| NK and T cell repertoire is established early after allogeneic HSCT and is profoundly imprinted by CMV reactivation | Blood advances | 2024 | 113 | 90 | |||
| Donation type and the effect of pre-transplant donor specific antibodies - Data from the Swiss Transplant Cohort Study | Frontiers in immunology | 2023 | 159 | 48 | |||
| CMV serostatus and T-cell repertoire diversity 5 years after allogeneic hematopoietic stem cell transplantation | Leukemia & lymphoma | 2023 | 75 | 78 | |||
| Clinical prediction model for prognosis in kidney transplant recipients (KIDMO) : study protocol | Diagnostic and prognostic research | 2023 | 78 | 213 | |||
| Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2) | Open forum infectious diseases | 2023 | 93 | 86 | |||
| Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2 : Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2) | Open forum infectious diseases | 2023 | 141 | 100 | |||
| HLA variants and TCR diversity against SARS-CoV-2 in the pre-COVID-19 era | HLA | 2023 | 107 | 92 | |||
| The impact of pre-transplant donor specific antibodies on the outcome of kidney transplantation – Data from the Swiss transplant cohort study | Frontiers in immunology | 2022 | 194 | 100 | |||
| Use of statins after liver transplantation is associated with improved survival: results of a nationwide study | Alimentary pharmacology & therapeutics | 2022 | 151 | 241 | |||
| Developing and testing a Corona VaccinE tRiAL pLatform (COVERALL) to study Covid-19 vaccine response in immunocompromised patients | BMC infectious diseases | 2022 | 143 | 84 | |||
| Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients | American journal of transplantation | 2022 | 244 | 139 | |||
| Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial | Clinical infectious diseases | 2022 | 150 | 79 | |||
| Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantation | Blood advances | 2021 | 320 | 133 | |||
| Infectious complications and graft outcome following treatment of acute antibody-mediated rejection after kidney transplantation: A nationwide cohort study | PLOS ONE | 2021 | 325 | 387 | |||
| Pre-transplant donor-specific HLA antibodies and risk for poor first-year renal transplant outcomes: results from the Swiss Transplant Cohort Study | Transplant international | 2021 | 249 | 395 | |||
| Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantation | Leukemia | 2020 | 403 | 304 | |||
| Preformed and de novo DSA are associated with T-cell-mediated rejection in pediatric liver transplant recipients requiring clinically indicated liver biopsy | Pediatric Transplantation | 2020 | 410 | 2 | |||
| Peripheral donor specific antibodies are associated with histology and cellular subtypes in protocol liver biopsies of pediatric recipients | Transplantation | 2020 | 372 | 207 | |||
| High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantation | Bone Marrow Transplantation | 2019 | 458 | 148 | |||
| Identification of seven novel HLA class I and II alleles | HLA | 2018 | 253 | 0 | |||
| Clinical and histological evolution after de novo donor-specific anti-human leukocyte antigen antibodies: a single centre retrospective study | BMC Nephrology | 2018 | 553 | 211 | |||
| Factors associated with immune hemolytic anemia after pediatric liver transplantation | Pediatric Transplantation | 2018 | 383 | 1 | |||
| Donor-specific antibodies C1q-binding: improvement in kidney graft management? | Transplant international | 2017 | 482 | 0 | |||
| Structural Basis of Bone Fragility in Young Subjects with Inflammatory Bowel Disease: A High-resolution pQCT Study of the SWISS IBD Cohort (SIBDC) | Inflammatory Bowel Diseases | 2017 | 583 | 1 | |||
| Identification of 3 novel HLA-B alleles: B*08:173, B*18:72:03 and B*53:05:02 | HLA | 2017 | 559 | 0 | |||
| Immunogenicity of anti-HLA antibodies in pancreas and islet transplantation | Cell transplantation | 2016 | 556 | 3 | |||
| Analysis and monitoring of anti-HLA antibodies in solid-organ and stem cell transplantation : What to do? When should they be tested? | 2015 | 718 | 423 | ||||
| Kidney paired donation: a plea for a Swiss National Programme | Schweizerische medizinische Wochenschrift | 2015 | 721 | 370 | |||
| Late antibody-mediated rejection by de novo donor HLA-DP-specific antibody after renal transplantation: a case report | Human immunology | 2014 | 573 | 0 | |||
| Expression of killer cell immunoglobulin-like receptors (KIRs) by natural killer cells during acute CMV infection after kidney transplantation | Transplant immunology | 2014 | 697 | 2 | |||
| The clinical relevance of pre-formed anti-HLA and anti-MICA antibodies after cord blood transplantation in children | PloS one | 2013 | 728 | 419 | |||
| Effects of an Interleukin-15 Antagonist on Systemic and Skeletal Alterations in Mice with DSS-Induced Colitis | The American journal of pathology | 2013 | 561 | 0 | |||
| HLA and non-HLA polymorphisms in renal transplantation | Schweizerische medizinische Wochenschrift | 2012 | 665 | 1 | |||
| Posttransplant cellular immune reactivity against donor antigen correlates with clinical islet transplantation outcome: towards a better posttransplant monitoring | Cell transplantation | 2012 | 616 | 0 | |||
| Detection of anti-HLA antibodies by solid-phase assay in kidney transplantation: friend or foe? | Tissue antigens | 2012 | 705 | 0 | |||
| Contact with stimulated T cells up-regulates expression of peptidylarginine deiminase 2 and 4 by human monocytes | European cytokine network | 2012 | 584 | 0 | |||
| Do RANKL inhibitors (denosumab) affect inflammation and immunity? | Osteoporosis international | 2011 | 703 | 1,061 | |||
| Eculizumab in acute recurrence of thrombotic microangiopathy after renal transplantation | American journal of transplantation | 2011 | 750 | 0 | |||
| De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients | American journal of transplantation | 2011 | 667 | 0 | |||
| Donor-specific antibody levels and three generations of crossmatches to predict antibody-mediated rejection in kidney transplantation | Transplantation | 2010 | 660 | 0 | |||
| Early relapse of autoimmune glomerulonephritis after kidney transplantation despite antibody induction and triple-drug-based immunosuppression | Transplantation | 2010 | 656 | 0 | |||
| Natural killer cell receptor--repertoire and functions after induction therapy by polyclonal rabbit anti-thymocyte globulin in unsensitized kidney transplant recipients | Clinical immunology | 2010 | 650 | 0 | |||
| RANKing bone resorption versus inflammation: Infection makes the decision | IBMS boneKEy | 2010 | 534 | 376 | |||
| Inhibition of T cell-dependent and RANKL-dependent osteoclastogenic processes associated with high levels of bone mass in interleukin-15 receptor-deficient mice | Arthritis and rheumatism | 2010 | 543 | 0 | |||
| Neural progenitors derived from human embryonic stem cells are targeted by allogeneic T and natural killer cells | Journal of Cellular and Molecular Medicine | 2009 | 609 | 166 | |||
| Humoral and cellular rejection after combined liver-kidney transplantation in low immunologic risk recipients | Transplant international | 2009 | 646 | 0 | |||
| Long-term insulin-independence after allogeneic islet transplantation for type 1 diabetes: over the 10-year mark | American journal of transplantation | 2009 | 981 | 6 | |||
| In vivo investigations on anti-fibrotic potential of proteasome inhibition in lung and skin fibrosis | American journal of respiratory cell and molecular biology | 2008 | 764 | 1 | |||
| Low risk of anti-human leukocyte antigen antibody sensitization after combined kidney and islet transplantation | Transplantation | 2008 | 927 | 0 | |||
| Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation | American journal of transplantation | 2008 | 776 | 0 | |||
| Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion | Blood | 2008 | 609 | 0 | |||
| IL-21 promotes survival and maintains a naive phenotype in human CD4+ T lymphocytes | International immunology | 2008 | 578 | 164 | |||
| The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors | Arthritis Research and Therapy | 2007 | 243 | 193 | |||
| Airway epithelial IL-15 transforms monocytes into dendritic cells | American journal of respiratory cell and molecular biology | 2007 | 621 | 1 | |||
| Anti-HLA antibody repertoire after IVIg infusion in highly sensitized patients waiting for kidney transplantation | Schweizerische medizinische Wochenschrift | 2006 | 530 | 387 | |||
| Acute humoral rejection in kidney allograft following a third-party arterial transplantation | American journal of transplantation | 2006 | 634 | 0 |
